Trexquant Investment’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Trexquant Investment’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-10,305	Closed	-$122K	–	1383
2017 Q3	$122K	Buy	+10,305	New	+$116K	0.03%	710
2017 Q2	–	Sell	-85,921	Closed	-$945K	–	1389
2017 Q1	$945K	Buy	85,921 +49,622	+137%	+$576K	0.12%	279
2016 Q4	$492K	Buy	+36,299	New	+$506K	0.08%	449
2016 Q3	–	Sell	-52,626	Closed	-$577K	–	1161
2016 Q2	$577K	Buy	+52,626	New	+$589K	0.08%	430
2015 Q3	–	Sell	-17,900	Closed	-$294K	–	1410
2015 Q2	$294K	Sell	17,900 -107,600	-86%	-$1.87M	0.03%	818
2015 Q1	$1.95M	Buy	125,500 +114,273	+1,018%	+$1.77M	0.2%	116
2014 Q4	$160K	Buy	+11,227	New	+$119K	0.03%	835

Other funds holding SCMP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Trexquant Investment's SCMP Position: Q4 2017 in Review

Trexquant Investment sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q4 2017, closing a stake of 10,305 shares — an estimated $122K sold.

Trexquant Investment first reported a position in SCMP in Q4 2014 and held it in 7 quarters. The position peaked at $1.95M in Q1 2015. 188 funds tracked by Wall St. Rank hold SCMP as of Q4 2017.

Trexquant Investment reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
Trexquant Investment sold 10,305 Sucampo Pharmaceuticals, Inc. shares in Q4 2017, an estimated $122K.
Trexquant Investment first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2014 and held it in 7 quarters.
Trexquant Investment's Sucampo Pharmaceuticals, Inc. position peaked at $1.95M in Q1 2015.
188 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2017.

Based on Trexquant Investment's 13F filing for Q4 2017, filed 9 Feb 2018.